122 related articles for article (PubMed ID: 11672825)
1. Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?
Mondelli MU; Cerino A; Segagni L; Meola A; Cividini A; Silini E; Nicosia A
Antiviral Res; 2001 Nov; 52(2):153-9. PubMed ID: 11672825
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
3. Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses.
Mondelli MU; Cerino A; Meola A; Nicosia A
J Biosci; 2003 Apr; 28(3):305-10. PubMed ID: 12734408
[TBL] [Abstract][Full Text] [Related]
4. Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus.
Keck ZY; Girard-Blanc C; Wang W; Lau P; Zuiani A; Rey FA; Krey T; Diamond MS; Foung SK
J Virol; 2016 Jan; 90(6):3112-22. PubMed ID: 26739044
[TBL] [Abstract][Full Text] [Related]
5. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
Zhou YH; Moriyama M; Esumi M
Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
[TBL] [Abstract][Full Text] [Related]
6. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
[TBL] [Abstract][Full Text] [Related]
8. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
9. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
10. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
11. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection.
Hjalmarsson S; Blomberg J; Grillner L; Pipkorn R; Allander T
J Med Virol; 2001 Jun; 64(2):117-24. PubMed ID: 11360243
[TBL] [Abstract][Full Text] [Related]
12. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
Shang D; Zhai W; Allain JP
Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
[TBL] [Abstract][Full Text] [Related]
14. Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.
Palmer BA; Schmidt-Martin D; Dimitrova Z; Skums P; Crosbie O; Kenny-Walsh E; Fanning LJ
J Virol; 2015 Dec; 90(7):3318-29. PubMed ID: 26719263
[TBL] [Abstract][Full Text] [Related]
15. Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV.
Mosa AI; AbouHaidar MG; Urbanowicz RA; Tavis JE; Ball JK; Feld JJ
Virol J; 2020 Sep; 17(1):140. PubMed ID: 32948191
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides.
Isaguliants MG; Widell A; Zhang SM; Sidorchuk A; Levi M; Smirnov VD; Santantonio T; Diepolder HM; Pape GR; Nordenfelt E
J Med Virol; 2002 Feb; 66(2):204-17. PubMed ID: 11782929
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.
Li C; Candotti D; Allain JP
J Virol; 2001 Dec; 75(24):12412-20. PubMed ID: 11711631
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.
Scarselli E; Cerino A; Esposito G; Silini E; Mondelli MU; Traboni C
J Virol; 1995 Jul; 69(7):4407-12. PubMed ID: 7539508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
